Cancer is the second leading cause of death in the United States, claiming nearly 575,000 lives a year. Those deaths are the result of over 200 types of cancer, some of which remain only partially understood. But thanks to research, this gap between what we do and do not understand about cancer is shrinking.
We continue to take significant strides in how we treat cancer, and Drexel University College of Medicine is proud to contribute to that advancement by educating future researchers through our Cancer Biology (CBIO) program.
The Cancer Biology program is one of the most unusual programs in the country, as it offers students ability to work alongside 35 top cancer researchers in the Philadelphia area, including scientists from top cancer institutions including Drexel University, The Wistar Institute, Fox Chase Cancer Center and Lankenau Institute for Medical Research.
The program provides a master's degree focused on the fundamentals of cancer from an interdisciplinary perspective, including molecular and cell biology of cancer initiation, metastasis, immunology, treatment and prevention while gaining experience in cutting edge technology. Graduates of the program gain comprehensive knowledge of molecular, cell and cancer biology, as well as expertise in the latest techniques used in cancer biology research.
Is Cancer Biology for Me?
The Cancer Biology program is designed for students who wish to pursue a career in basic and applied cancer research, leading them to investigate the molecules, mechanisms, and pathways involved in the development of this disease.
Students in the program come from many backgrounds including:
- New college graduates
- Recent college graduates interested in career changes
- Laboratory technicians
- Industrial and biotechnology employees
Upcoming and Recent Events
Molecular & Cell Biology & Genetics/Cancer Biology Program Rotation Talks
Thursday, May 26, 2016 at 1 p.m.
New College Building, Biochemistry Library Room 11101, 245 North 15th Street | Video conference to QL C9
Speakers: MCBG and CB first-year graduate students
- Chaitali Bhadiadra, MCBG Program
Using cancer genomic databases to identify glycosyltransferases involved in cancer
Advisor: Dr. Mauricio Reginato
- Erica Dalla, CB Program
Investigating the role of the chemokine receptor CX3CR1 in a preclinical model of metastatic inflammatory breast cancer
Advisor: Dr. Olimpia Meucci
- Leann Dudash, MCBG Program
Combining rapamyacin treatment and methionine restriction increases autophagy in human cardiac fibroblasts
Advisor: Dr. Chris Sell
- Waleed Iqbal, CB Program
Exogenous pyruvate facilitates cancer cell adaption to hypoxia
Advisor: Dr. Nianli Sang
- Dimpi Mukhopadhyay, CB Program
Cloning full-length and individual domains of PPIE
Advisor: Dr. Tara Davis
- Kris Raghavan, MCBG Program
Identifying stroma-derived exosomes in pancreatic cancer
Advisor: Dr. Edna Cukierman
How to apply to the Cancer Biology program
Back to Top